chrisvoncsefalvay/vaers-outcomes huggingface dataset:
More than 35 days after the first dose without receiving the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (More than 35 days after the first dose without receiving the second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 35 days after the first dose without receiving the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (More than 35 days after the first dose without receiving the second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided  No treatment medications were provided by the reporter.    Reporter did not allow further contact
Pt had chest tightness, diaphoresis, and shortness of breath after receiving the Covid vaccine. Symptoms lasted about 15 minutes then completely resolved. He went to the ED for evaluation. He also had a mild headache, which was treated with Tylenol.
Swollen, painful lymph nodes under arm starting at 11PM on 20 January. Still ongoing.
Roughly 15 minutes after the vaccine I began to blackout. I did not fully lose consciousness but my field of vision was taken over by spots and stars. My blood pressure was very low. After being monitored for 45 mins I felt well enough to go home.
Sudden numbness in legs (ascending from toes), loss of ability to walk or stand, hospital diagnosis of GUILLAIN-BARRE Syndrome, 5 day course of IV immunoglobulin treatment, required inpatient acute physical therapy (currently ongoing for at least 2-4 weeks).
A 16 year old patient received the moderna COVID 9 vaccination.  No adverse events or symptoms to report at this time.
A day after the vaccine I woke up with a sore arm and swelling under my arm, It started to go down after 3-4 days but my chest was really sore. I then noticed that my heart rate was 10-15 more than normal, I then went to the doctor a week and they said I had a irregular heart beat and I'm now awaiting my appointment for my mammogram in May.
Very painful; burning in arm; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain and burning sensation. On an unknown date, the outcome of the pain and burning sensation were not recovered/not resolved.   It was unknown if the reporter considered the pain and burning sensation to be related to Shingles vaccine.  Additional details were provided as follows: The case was self reported by the patient. The age at vaccination was not reported. The reporter got the shot and was still feeling burning in arm from having them, was very painful. The reporter stated that, he/she had been down that road and did not ever wanted to again. For tolerance of 2nd dose, refer case US2021AMR231058, reported by same reporter. The follow-up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR231058:2nd dose
36 year old female with no other comorbidities presents 4 days after vaccine with complaints of right sided neck swelling and pain. Physical examination reveals right anterior neck lymphadenopathy. Patient states she has never had any previous reactions to any other vaccines. Patient is taking tylenol 1000mg q 8 hours PRN with little effect. Patient has no history of auto-immune disorders or any family history of immune disorders at this time.
Impaired right eye vision.   01/29/2021- Retina Specialist diagnosed: Hemiretinal Vein Occlusion Right Eye. Will begin treatment for ocular injections in the next week
My arm itched and I had a red swollen rash around the injection site. It was warm to the touch and lasted several days.
24MAR98 @ 11PM pt had temp of 100-101ax;MN was sleeping then began shaking for 30-60 seconds;made noise, urinated;was postictal for 20min;had fever 105 @ 3AM on 25MAR98 for 2 days;seen in office 26MAR98;
Itching and feels heavy; changed to a reddish-brown color; swollen glands under arm; red and as big as her hand on arm; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching and feels heavy), SKIN DISCOLOURATION (changed to a reddish-brown color), LYMPHADENOPATHY (swollen glands under arm) and VACCINATION SITE ERYTHEMA (red and as big as her hand on arm) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching and feels heavy), SKIN DISCOLOURATION (changed to a reddish-brown color), LYMPHADENOPATHY (swollen glands under arm) and VACCINATION SITE ERYTHEMA (red and as big as her hand on arm). The patient was treated with IBUPROFEN (ADVIL 12HOUR) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching and feels heavy), SKIN DISCOLOURATION (changed to a reddish-brown color), LYMPHADENOPATHY (swollen glands under arm) and VACCINATION SITE ERYTHEMA (red and as big as her hand on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       patient also used cold packs as treatment.
arm hurt; back of shoulder hurt; chest tightness/Chest was like a little tight; Voice was Rusty/had a hoarse voice; lethargic; Wheezing; sweats; body aches; fatigued; allergies; This is a spontaneous report from a contactable consumer (patient). A 58-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Lot Number: EN6207), dose 1 via an unspecified route of administration, administered in Left arm on 19Mar2021 at 01:00 (58-year-old at the time of vaccination) as dose 1, single for covid-19 immunisation. Medical history included hbp (high blood pressure) from an unknown date and ongoing and thyroid disorder from an unknown date and unknown if ongoing. The patient had allergies. Concomitant medications included Levothyroxine sodium (LEVOXYL), Pregabalin (LYRICA), Salbutamol Sulfate (INHALERIN); all for unknown indications from unknown dates and unknown if ongoing. On 19MAR2021, the patient was very lethargic. On 20MAR2021, the patient experienced her arm and back of shoulder hurt, chest tightness/Chest was like a little tight and Voice was Rusty/had a hoarse voice. On an unspecified date in 2021, the patient experienced sweats, body aches, fatigued, allergies and wheezing. The patient got the vaccine on Friday, and did not have any symptoms in the morning but then the next day her arm and back of shoulder hurt, also with her chest she had tightness, the patient also had a hoarse voice and was fatigued. The patient was concerned with chest tightness and the hoarseness, wanting to know if that was a normal side effect and if she is okay to get the second dose. Because of the patient's allergies, is the second dose going to be worse. Last night the patient had sweats and body aches, she does not know if that was normal. The patient stated that all her symptoms at the moment are getting better, but she is still just tired. The patient wanted to know if her main concern if she will be okay to get the second shot, since she had the chest tightness, wheezing, and hoarse voice. The outcome of the events were un-known.  No follow-up attempts are needed. No further information is expected.
Information has been received from a licensed practical nurse (L.P.N.) concerning a 28-year-old female with no medical history or allergies, who in 2001 was vaccinated with a dose of MMR II. There was no concomitant medication. On 20-OCT-2006 the patient had a mumps titer drawn, it was reported that the titer was 0.13. Unspecified medical attention was sought and the patient was vaccinated with a dose of MMR II due to the low mumps titer and a low Varicella titer, less than 0.9. (WAES# 0703USA05492). It was reported that the patient had not recovered. No product quality complaint was involved. Additional information has been requested.
Mild allergic reaction.  Hour 6- Around hour 6 or 7 (somewhere between 1 and 3 am of 4/7), while fighting the fever the first episode of the numbing occurred. Alongside the hot/cold chills my exterior mouth and left lower face went numb, followed by left arm, down body to left foot. I feel asleep eventually and woke up and this was gone. injection site sore.  Hour 40- woke up with swollen and numb lips. lower left facial numbness and left hand numbness returned. injection site still sore.  hour 60- woke up with swollen and numb tongue. still had swollen and numb lips. lower left facial numbness and left hand numbness remained as well. injection site still sore.  Hour 84- woke up with numbness in the back of my throat and swelling of exterior throat. Rest of symptoms dissipating some - Still had slightly swollen and numb tongue and lips. Slight lower left facial numbness and left hand numbness remained as well. injection site only sore to touch the area.  Hour 108 -current: All symptoms dissipating some - Very slight numbness in the back of my throat, tongue, and lips.  swelling of exterior throat. Slight lower left facial numbness and left hand numbness when I make a fist. injection site only sore to touch the injection site exactly.
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On unknown dates, the patients were vaccinated with improperly stored GARDASIL (unknown strength and dose) lot # L033347 and expiry date of 23-JUL-2017. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
still have numbness on two fingers; still have a radiating tingling sensation goin up their arm, not constant, for almost 4 month now; uncomfortable feeling; soreness of the arm after both shots; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA (still have numbness on two fingers), PARAESTHESIA (still have a radiating tingling sensation goin up their arm, not constant, for almost 4 month now), FEELING ABNORMAL (uncomfortable feeling) and PAIN IN EXTREMITY (soreness of the arm after both shots) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (still have numbness on two fingers), PARAESTHESIA (still have a radiating tingling sensation goin up their arm, not constant, for almost 4 month now), FEELING ABNORMAL (uncomfortable feeling) and PAIN IN EXTREMITY (soreness of the arm after both shots). The patient was treated with VITAMIN B12 [VITAMIN B12 NOS] at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (still have numbness on two fingers), PARAESTHESIA (still have a radiating tingling sensation goin up their arm, not constant, for almost 4 month now) and FEELING ABNORMAL (uncomfortable feeling) had not resolved and PAIN IN EXTREMITY (soreness of the arm after both shots) outcome was unknown.            No Concomitant medications were reported. HCP recommended to ice the area.
weakness; fever; chills; a little sore in right arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Mar-2021 and was forwarded to the company on 22-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a little sore in right arm), ASTHENIA (weakness), PYREXIA (fever) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (a little sore in right arm). On 14-Mar-2021, the patient experienced ASTHENIA (weakness), PYREXIA (fever) and CHILLS (chills). On 19-Mar-2021, ASTHENIA (weakness), PYREXIA (fever) and CHILLS (chills) outcome was unknown. At the time of the report, PAIN IN EXTREMITY (a little sore in right arm) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, Body temperature: 98.8 (High) 98.8 Degree Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. No treatment medication information was provided.
under 18-year-old received the first dose of moderna; Second dose administered with Pfizer COVID-19 Vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under 18-year-old received the first dose of moderna) and INTERCHANGE OF VACCINE PRODUCTS (Second dose administered with Pfizer COVID-19 Vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under 18-year-old received the first dose of moderna) and INTERCHANGE OF VACCINE PRODUCTS (Second dose administered with Pfizer COVID-19 Vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under 18-year-old received the first dose of moderna) and INTERCHANGE OF VACCINE PRODUCTS (Second dose administered with Pfizer COVID-19 Vaccine) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.   Patient stated that first dose was received on 2021 and also stated that second dose with Pfizer COVID-19 Vaccine was received on 03 or 04JUL2021
Based on additional information received on 31 March 2015, this case initially considered as non-serious was upgraded to serious: Important Medical Event (Guillain Barre syndrome) and was also medically confirmed. Initial unsolicited misuse report received from a consumer on 07 October 2014. A 51-year-old female patient, concomitant medications were not reported had received first intramuscular dose of FLUZONE HD batch number: U5019AA (expiry date and site of administration not reported), on 30 September 2014. Patient denied to provide medical history. On 01 Oct 2014 i.e. 1 day after vaccination the patient developed central nervous system symptoms of pins and needles of both upper and lower extremities and dizziness. The patient stated that it felt as if things were crawling all over both legs and arms. The patient was evaluated and treated with steroids, which were effective in decreasing the severity of the symptoms. The patient had plans to follow up with physician on 07 October 2014. Laboratory investigations were not reported. The outcome of the event was not reported. List of documents held by sender: none. Follow up information received from a pharmacist on 31 March 2015 and 09 April 2015. Expiry date of FLUZONE HD was reported as 10 April 2015. It was reported the patient received FLUZONE HD at the age of 51 years old, thus was vaccinated at an inappropriate age. Post vaccination patient experienced chills, tingling of hands and feet, weakness in legs, dizziness, exhaustion, and feeling of no energy. The patient continued to have symptoms of tingling of arms and legs, weakness, dizziness, exhaustion, and had no energy. The patient was treated with 60 g of KENALOG given intramuscularly in right gluteal region. The symptoms persisted and she was referred to the neurologist for concern regarding GB syndrome. Follow up information received from a pharmacist on 8 September 2015. It was reported that on an unspecified date, fatigue has returned, she was not able to work since vaccination, sleeping 15 hours per day and taking naps. It was also reported that she had severe right epigastric pain, had 2 polyps in her gallbladder and 3 kidney stones. The patient was taking vitamins. It was reported that the patient still experiencing same symptoms as previously and she was not recovered from the events. She wanted to know how to get the toxins out of her body. The patient required emergency and physician visit.
Patient received PNEUMOVAX on 12/11/12. Noticed some redness and pain later that night. Was seen at clinic 12/12/12, not treated. Seen by us 12/13/12 with palm sized redness, warmth, induration. Diagnosed with cellulitis and was treated with BACTRIM.
this child was supposed to get a DTaP (Infanrix) and received a Pediarix instead
Administration of AFLURIA and PREVNAR 13 in same arm on 10/6/2016. On 10/13/2016, she called saying her arm was very sore and "a little red". I told her to take ibuprofen and ice arm. Since 2 week went by from administration and pain still. Suggesting a dr look at arm if she feels it is necessary.
sore arm; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A 71-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 22Sep2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm".  Additional information: Patient got two doses of the Comirnaty 18 days apart. The first one on 22Sept2023. She mentioned, She had not have any side effects other than a sore arm.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300324867 same reporter/patient/product, different dose/AE;
patient said the next day after the shot, she started having severe itching on her forearms and lower legs only . She started taking Zyrtec and benadryl which has helped her itching a lot
received 1st dose 2 years ago, series not completed; This case was reported by a other health professional via sales rep and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose 2 years prior to the reporting).   On an unknown date, the patient did not  received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 06-JUL-2022 Reporter's Comment:  Reporter stated patient received 1st dose of Shingrix 2 years ago. Patient wanted to know if patient should restart the series or should just get 2nd dose. No additional details as this was the only information provided. Additional supportive information Till the time of reporting patient did not received second dose of vaccine which led to inappropriate schedule of vaccine. Reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR103676:Same reporter. Patient 2
No adverse event; The vaccine was given 2 days past BUD; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vaccine was given 2 days past BUD) and NO ADVERSE EVENT (No adverse event) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 26-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vaccine was given 2 days past BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vaccine was given 2 days past BUD) had resolved and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (The vaccine was given 2 days past BUD).    No concomitant medication were provided No treatment details were provided
pt recv vax 1996 & 6AUG97 pt devel significant shingles along lt flank p/being exposed to varicella 2wk prior;the shingles were described red, vesicular & tender;10AUG97 pt recovered;
Began with severe chills and fever.  Fever persisted through third day.  Injection site became red and swollen.  Swelling and redness spread down arm and became hot. Also became itchy.  Muscle hard, not soft like other arm.  Fatigue, body aches, headaches. All symptoms except chills still present 6 days after injection.
Site injection soreness; Site injection soreness, fatigue; This is a spontaneous report from a contactable consumer (Patient) or other non hcp. A 60-years-old female patient received bnt162b2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN8730) dose 1 via an unspecified route of administration, administered in arm Left on 29Mar2021 02:00 as single dose for covid-19 immunisation. Medical history included blood cholesterol increased. Concomitant medications included simvastatin (SIMVASTATIN), ergocalciferol (CALCIFEROL VIT D), omega-3 (OMEGA-3 NOS) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. She experienced site injection soreness and fatigue. The patient did not receive treatment for the events. The outcome of the events were recovered.  No follow-up attempts are needed. No further information is expected.